Send me a link:

*Text messaging rates may apply.

 Dow Up0.36% Nasdaq Up0.71%

Esperion Therapeutics, Inc. (ESPR)

-NasdaqGM
14.49 Up 0.06(0.42%) 4:00PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 31, 2014Dec 31, 2013Sep 30, 2013Jun 30, 2013
Total Revenue -   -   -   -  
Cost of Revenue -   -   -   -  
Gross Profit -   -   -   -  
Operating Expenses
Research Development5,400  7,339  3,483  3,100  
Selling General and Administrative2,490  2,397  1,924  1,172  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (7,890) (9,736) (5,407) (4,272)
Income from Continuing Operations
Total Other Income/Expenses Net16  47  168  (2,541)
Earnings Before Interest And Taxes(7,874)(9,689)(5,238)(6,813)
Interest Expense -   -   -  109  
Income Before Tax(7,874)(9,689)(5,238)(6,921)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(7,874)(9,689)(5,238)(6,921)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (7,874) (9,689) (5,238) (6,921)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (7,874) (9,689) (5,238) (6,921)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.